Abstract: A display apparatus includes a display panel, a rear chassis supporting the display panel. The rear chassis includes a rear cover covering a rear side of the display panel, and a side cover protruding from an edge of the rear cover and covering an edge of the display panel, and a mounting bracket mounted on the rear chassis. The mounting bracket includes, a bracket body on an outer surface of the side cover, a hook portion protruding from a first end of the bracket body and to receive a portion of the side cover, and a fixing protrusion protruding from a second end of the bracket body and to contact a rear surface of the rear cover to fix the mounting bracket to the rear chassis.

Abstract: A display apparatus includes: a display panel; an optical member on a rear side of the display panel; a rear chassis configured to support the display panel and the optical member; and a supporter between the optical member and the rear chassis, where the supporter includes: a plate portion on a front surface of the rear chassis; a base portion including a first end and a second end, the first end being connected to the plate portion and the second end being spaced apart from the plate portion; and a protrusion protruding forwardly from the base portion.

Abstract: An intrasaccular implant for vascular occlusion of an aneurysm comprises a self-expanding braided mesh body configured for constrained delivery through a catheter and expansion within an aneurysm sac. The braided mesh body includes a distal loop portion configured to contact a distal wall of the aneurysm sac over a widened contact area during deployment, a proximal loop portion configured to be positioned adjacent an aneurysm neck, and an intermediate portion between the distal loop portion and the proximal loop portion. The braided mesh body is configured such that, during deployment from the catheter, the distal loop portion expands before the proximal loop portion and the braided mesh body foreshortens in stages as successive loop portions expand. The proximal loop portion defines a recessed proximal region configured to house a release mechanism such that the release mechanism does not protrude beyond a proximal end of the implant after deployment.

Abstract: The present invention pertains to a thrombectomy device comprising a cylindrical proximal portion, a dome-shaped distal portion, a transition portion, and a coil. The cylindrical proximal portion forms a stent frame having a first lattice network of a first plurality of interconnecting segments. The first plurality of interconnecting segments is configured to exert a first radial force against an inner wall of a blood vessel. The dome-shaped distal portion forms a protection cage having a second lattice network of a second plurality of interconnecting segments. The second plurality of interconnecting segments is configured to exert a second radial force against the inner wall of the blood vessel. The transition portion is arranged between the stent frame and the protection cage. The coil is formed at a distal end of the protection cage.

Abstract: The present invention pertains to a left arterial appendage device comprising a cylindrical proximal hub and a plurality of looping struts forming a circle. The plurality of looping struts are interconnected only at the proximal hub, and are otherwise unconstrained to support a rolling action which allows the device to be delivered intravascularly through a catheter or similar introducer tube. The distal end of the looping strut moves radially inward towards the center of a spiral created by the looping strut, minimizing risk of causing damage to surrounding tissue, increasing density at the neck, and providing radial force for device retention.

Abstract: A microsphere contains varenicline hemipamoate and a biocompatible polymer. A method of preparing the microsphere, and a pharmaceutical composition containing the microsphere are disclosed. The microsphere containing varenicline encapsulates a high concentration of varenicline, and exhibits a stable drug release rate over a long period of time and an appropriate initial release rate, and thus can maintain varenicline at an effective concentration in the blood for a certain period of time without side effects.

Abstract: A display apparatus includes a display; a stand, and a control device. The stand includes a stand body and a bolt. The bolt may be configured to protrude from the stand body. The control device is electrically connectable to the display and includes a mounting hole on the side. The stand and the control device may be configured so that the bolt protruding from the stand body may be inserted into the mounting hole to mount the control device on the stand. The control device mounted on the stand is supported by the stand.

Abstract: An immune-proteomic screening of AAb responses using protein arrays has identified two panels of Aab (antigen/antibody complexes) that can potentially differentiate lung adenocarcinoma from smoker controls as well as CT positive benign lung disease. The resulting biomarkers appear to have high specificity so that high risk subjects with a positive CT screen and a positive serum test should get more invasive test such as needle biopsy for a timely cancer diagnosis, among other advantages.

Abstract: The present invention relates to a haptic feedback system, and in particular to a device and method for rapidly removing residual vibration in a linear resonant actuator, the method driving the linear resonant actuator by applying a resonant frequency thereto to implement a haptic function and applying a braking signal for removing the residual vibration after the driving of the linear resonant actuator, wherein the braking signal is a driving wave for generating the same vibration waveform as a residual vibration waveform of the linear resonant actuator, and is applied to the linear resonant actuator at a point of time when a BEMF signal of the linear resonant actuator crosses a zero point, the braking signal being applied in an opposite direction in which it is possible to cancel the residual vibration waveform of the linear resonant actuator.

Abstract: A method of implanting and securing an implantable flow connector in a body of a patient for providing communication of a first space within the body of the patient with a second space within the body of the patient. The method includes providing a flow connector having a lumen having a first orifice and a second orifice, inserting a retention device into the first space within the body, subsequently inserting the flow connector through an opening in the retention device so the second portion of the flow connector extends into the first space within the body and placing the second space within the body over the retention device.

Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.

Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).

Abstract: The present invention pertains to a thrombectomy device comprising a cylindrical proximal portion, a dome-shaped distal portion, a transition portion, and a coil. The cylindrical proximal portion forms a stent frame having a first lattice network of a first plurality of interconnecting segments. The first plurality of interconnecting segments is configured to exert a first radial force against an inner wall of a blood vessel. The dome-shaped distal portion forms a protection cage having a second lattice network of a second plurality of interconnecting segments. The second plurality of interconnecting segments is configured to exert a second radial force against the inner wall of the blood vessel. The transition portion is arranged between the stent frame and the protection cage. The coil is formed at a distal end of the protection cage.

Abstract: Disclosed is a method of functional genomics determination including transducing a cell population with a set of nucleic acid molecules including a pooled library of genomic perturbagens to integrate multiple perturbagen cassettes into the genome. A phenotype of individual cells is determined and single cells of the population with targeted phenotypes are individually sorted into a set of compartments. Each compartment includes a forward primer with a nucleic acid sequence (NAS) that specifically binds a common nucleic acid sequence on the nucleic acid molecules and a compartment (cell)-specific nucleic acid barcode. Also included is a reverse primer with a NAS that specifically binds a common NAS on the nucleic acid molecules comprising a pooled library of genomic perturbagens. The genome-integrated perturbagen cassettes are create amplicons which are pooled and sequences determined.

Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).

Abstract: A display apparatus including display panel, a rear case to cover a rear of the display panel and the rear case including a cable fixing hole to which a cable is fixed, a connector connected to the cable and fastened to the rear case so that the cable is connected to the rear case, a cable holder to surround a part of the cable and fixed to the cable fixing hole so that the cable is fixed to the rear case, and a clamp to fix the cable holder to the cable fixing hole, wherein the clamp includes a first hook to be fixed to the cable fixing hole, and a second hook having a different shape than a shape of the first hook and to be fixed to the cable fixing hole to have a greater fixing force than a fixing force of the first hook.

Abstract: A stent delivery system for in-situ deployment of a self-expanding stent is described. The stent delivery system includes a self-expanding stent retention sleeve and a pushwire disposed inside the self-expanding stent retention sleeve. The self-expanding stent retention sleeve includes a proximal end, a distal end, and a central section having a plurality of slots that form a plurality of struts in the central section. The distal end of the pushwire has at least one groove formed therein, which releasably couples with at least one protrusion formed at a proximal end of the self-expanding stent. The distal end of the self-expanding stent retention sleeve moves toward the proximal end of the self-expanding stent retention sleeve when the self-expanding stent retention sleeve is in an unconstrained configuration, thereby releasing the at least one protrusion from the at least one groove to deploy the self-expanding stent.

Abstract: A stent having a substantially tubular body is disclosed. In at least one embodiment, the stent provides a scaffold having a plurality of interconnected struts forming a plurality of radial axial rows of radial support cells and a plurality of flexible axial rows of flexible support cells. The plurality of radial axial rows and flexible axial rows are disposed in an alternating pattern along a circumferential axis of the stent. A center axis of each radial axial row and flexible axial row is parallel to a longitudinal axis of the stent. Each radial axial row is arranged so as to be offset along the longitudinal axis of the stent from each adjacent radial axial row. Each radial support cell is formed from four of the interconnected struts of the scaffold which are arranged so as to be symmetrical along both the longitudinal axis and the circumferential axis of the stent.

Abstract: The present invention relates autoantibody biomarkers, kits, and methods for increasing the accuracy of a cancer or autoimmune screening of a subject suspected of having cancer or an autoimmune condition.